Skip to main content

Table 2 Expression of surface antigens on peripheral blood monocytes in the studied women

From: Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies

Laboratory Data Endometrial Cancer (N = 42) Cervical Cancer (N = 13) Ovarian Cancer (N = 14) Group I (N = 20) Group II (N = 23)
CD11a (%) 99.98 ± 0.06; 99.94 ± 0.21; 99.44 ± 1.94; 99.99 ± 0.05; 99.96 ± 0.09;
100.00 100.00 100.00 100.00 100.00
(99.74-100.00) (99.23-100.00) (92.72-100.00) (99.79-100.00) (99.59 -100.00)
CD11b (%) 99.72 ± 0.73; 99.35 ± 1.60; 99.87 ± 0.16; 99.72 ± 0.45; 99.91 ± 0.16;
99.87 * 99.86 * 99.93 99.93 * 100.00
(95.28-100.00) (94.08-100.00) (99.40-100.00) (98.07-100.00) (99.47-100.00)
CD11c (%) 99.54 ± 1.36; 97.62 ± 6.74; 98.27 ± 5.87; 99.77 ± 0.37; 99.40 ± 2.37;
100.00 99.93 100.00 99.96 100.00
(92.49-100.00) 75.38-100.00) (77.93-100.00) (98.91-100.00) (88.63-100.00)
CD16 (%) 17.86 ± 22.51; 11.99 ± 18.09; 26.19 ± 31.96; 16.99 ± 26.21; 10.64 ± 4.95;
7.19 6.16 * 8.84 6.37 ** 9.55
(2.39-83.80) (1.23-69.87) (4.24-91.53) (2.78-85.20) (5.23-28.30)
CD54 (%) 83.89 ± 16.44; 87.27 ± 12.32; 89.86 ± 11.94; 92.40 ± 9.16; 63.82 ± 15.21;
88.46 *** 91.46 *** 94.57 *** 97.00 *** 65.20
(27.75-100.00) (68.40-100.00) (63.90-100.00) (69.87-100.00) (21.61-91.75)
CD62L (%) 97.64 ± 2.06; 96.51 ± 4.99; 98.80 ± 1.51; 93.69 ± 9.74; 96.56 ± 2.83;
98.35 97.85 99.18 *** 98.23 97.01
(93.00-100.00) (80.38-99.54) (94.74-100.00) (67.94-99.86) (85.40-99.70)
CD64 (%) 95.57 ± 9.06; 93.38 ± 7.42; 97.88 ± 4.67; 96.80 ± 5.22; 99.39 ± 1.19;
99.16 *** 96.30 ** 99.65 99.59 * 99.91
(47.60-100.00) (76.60-100.00) (82.13-100.00) (81.93-100.00) (95.15-100.00)
HLA-DR (%) 80.94 ± 15.85; 68.50 ± 25.66; 73.98 ± 16.60; 70.22 ± 24.76; 94.98 ± 5.66;
85.80 *** 76.60 *** 73.35 *** 79.70 *** 96.10
(33.13-99.71) (18.50-95.83) (27.65-95.21) (17.33-99.37) (73.48-99.63)
  1. Group I - women operated but had no malignancy in postoperative histopathologic examination, Group II - healthy women. SD - standard deviation, CD - cluster of differentiation molecule, HLA-DR - membrane receptor: Human leukocyte antigen-DR (product of hla-dr locus). Data are presented as: mean ± 1 SD, median (minimum-maximum). Asterisks indicate statistically significant differences in Mann–Whitney U test: * - p < 0.05; ** - p < 0.01; *** - p < 0.001, in comparison to Group II.